Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heald

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Cardiovascular Endocrinology & Metabolism|June 14, 2021
Dapagliflozin: an effective adjunctive treatment in type 1 diabetesGhasem Yadegarfar, Mark Livingston, Gabriela Cortes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 22, 2021
The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetesAdrian H Heald, Michael Stedman, Linda Horne, et al.
Diabetes|November 25, 2005
Polymorphisms in IGF-binding protein 1 are associated with impaired renal function in type 2 diabetesRichard H Stephens, Patrick McElduff, Adrian H Heald, et al.
International Journal of Clinical Practice|October 28, 2015
Are cholesterol levels being checked and managed appropriately in UK primary care type 2 diabetes?M Livingston, J C Robinson, C E Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 4, 2025
Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoringAdrian H Heald, Mike Stedman, Angela Paisley, et al.
Atherosclerosis|July 12, 2014
Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European originS G Anderson, D C Hutchings, A H Heald, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformedAdrian H Heald, John Warner-Levy, Lleyton Belston, et al.
Cardiovascular Endocrinology & Metabolism|November 23, 2020
The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UKGhasem Yadegarfar, Simon G Anderson, Zohaib Khawaja, et al.
Frontiers in Psychology|May 30, 2017
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These ConditionsAdrian H Heald, Andreas Walther, Julian R E Davis, et al.
Annals of General Psychiatry|November 20, 2015
Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective surveySimon G Anderson, Mark Livingston, Lewis Couchman, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Cardiovascular Endocrinology & Metabolism|June 14, 2021
Dapagliflozin: an effective adjunctive treatment in type 1 diabetesGhasem Yadegarfar, Mark Livingston, Gabriela Cortes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 22, 2021
The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetesAdrian H Heald, Michael Stedman, Linda Horne, et al.
Diabetes|November 25, 2005
Polymorphisms in IGF-binding protein 1 are associated with impaired renal function in type 2 diabetesRichard H Stephens, Patrick McElduff, Adrian H Heald, et al.
International Journal of Clinical Practice|October 28, 2015
Are cholesterol levels being checked and managed appropriately in UK primary care type 2 diabetes?M Livingston, J C Robinson, C E Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 4, 2025
Consistency of the personalized glycated haemoglobin (pHbA1c) methodology over time in people with type 1 diabetes (T1D) using continuous glucose monitoringAdrian H Heald, Mike Stedman, Angela Paisley, et al.
Atherosclerosis|July 12, 2014
Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European originS G Anderson, D C Hutchings, A H Heald, et al.
Cardiovascular Endocrinology & Metabolism|October 2, 2023
Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformedAdrian H Heald, John Warner-Levy, Lleyton Belston, et al.
Cardiovascular Endocrinology & Metabolism|November 23, 2020
The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UKGhasem Yadegarfar, Simon G Anderson, Zohaib Khawaja, et al.
Frontiers in Psychology|May 30, 2017
No Difference in Mood and Quality of Life in DHEA-S Deficient Adults with Addison's Disease vs. Type 2 Diabetes Patients with Normal DHEA-S Levels: Implications for Management of These ConditionsAdrian H Heald, Andreas Walther, Julian R E Davis, et al.
Annals of General Psychiatry|November 20, 2015
Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective surveySimon G Anderson, Mark Livingston, Lewis Couchman, et al.
Pageof 19